1-3 of 3
Xueli Jin
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Integrated genomic and tumor microenvironment subtyping refines risk stratification in primary central nervous system lymphoma

Free
Xianggui Yuan, Qian Luo, Yurong Huang, Chaoyi Li, Teng Yu, Shanshan Guo, Qunyi Guo, Xueli Jin, Jiefeng Tong, Aiqi Zhao, Wen Lei, Xian Li, Baizhou Li, Shumei Wei, Wenbin Qian, Yun Liang
Journal: Blood
Blood (2025) 146 (Supplement 1): 5304.
https://doi.org/10.1182/blood-2025-5304
Published: 2025
Journal Articles

Orelabrutinib, sintilimab, and temozolomide (OST) in relapsed/refractory primary central nervous system lymphoma

Free
Xianggui Yuan, Yurong Huang, Qunyi Guo, Yaping Xie, Nengwen Xu, Xueli Jin, Jiefeng Tong, Yun Liang, Wenbin Qian
Journal: Blood
Blood (2025) 146 (Supplement 1): 5461.
https://doi.org/10.1182/blood-2025-5461
Published: 2025
Journal Articles

Efficacy and Safety Analysis of Ibrutinib-Containing Therapy for Relapsed/Refractory (R/R) Mantle Cell Lymphoma (MCL): Results from a Real-World Study in China

Free
Qingqing Cai, PhD, Huiqiang Huang, MDPhD, Yuchen Zhang, Panpan Liu, MD PhD, Hongmei Jing, MD PhD, Ping Yang, MD PhD, Tongyu Lin, MD PhD, Zhongjun Xia, MDPhD, Zhiming Li, MD PhD, Wenyu Li, PhD, Liye Zhong, MD PhD, Xu Ye, MD PhD, Xueli Jin, MD PhD, Liling Zhang, MD PhD, Huilai Zhang, MD PhD, Xiuhua Sun, MD, Yuyang Tian, MM, Shuyun Ma, MM, Ning Su, MM, Jun Cai, BMBS
Journal: Blood
Blood (2020) 136 (Supplement 1): 1.
https://doi.org/10.1182/blood-2020-136842
Published: 2020